|
|
|
Insider
Information: |
Holmes Scott A |
Relationship: |
Chief Financial Officer |
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
51,958 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$714,423 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
51,958 |
|
|
Total
Value |
$714,423 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
AMAG Pharmaceuticals Inc |
AMAG |
SVP, Finance and Treas... |
2015-06-15 |
51,958 |
2012-09-12 |
0 |
Premium* |
|
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2018-12-12 |
0 |
2015-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2017-04-28 |
4 |
S |
$5.89 |
$7,180 |
D/D |
(1,219) |
146,404 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2017-05-01 |
4 |
S |
$5.97 |
$8,603 |
D/D |
(1,441) |
144,963 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2017-10-30 |
4 |
S |
$6.03 |
$15,569 |
D/D |
(2,582) |
139,700 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2017-07-28 |
4 |
S |
$6.96 |
$8,603 |
D/D |
(1,236) |
143,727 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2017-07-31 |
4 |
S |
$7.14 |
$10,317 |
D/D |
(1,445) |
142,282 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2016-07-29 |
4 |
S |
$7.36 |
$36,322 |
D/D |
(4,935) |
108,557 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
|
2015-07-31 |
4 |
S |
$7.87 |
$21,705 |
D/D |
(2,758) |
49,742 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP, Finance and Treasurer |
|
2015-06-03 |
4/A |
OE |
$14.38 |
$370,011 |
D/D |
22,516 |
53,304 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Accounting Officer |
|
2012-12-05 |
4 |
AS |
$14.79 |
$36,975 |
D/D |
(2,500) |
0 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP, Finance and Treasurer |
|
2015-06-15 |
4 |
OE |
$14.89 |
$98,634 |
D/D |
6,234 |
58,192 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Accounting Officer |
|
2012-09-12 |
4 |
AS |
$15.54 |
$11,655 |
D/D |
(750) |
0 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
VP, Chief Accounting Officer |
|
2013-12-16 |
4 |
D |
$23.23 |
$15,192 |
D/D |
(654) |
11,596 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
|
2014-12-17 |
4 |
D |
$40.49 |
$34,781 |
D/D |
(859) |
48,837 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
|
2015-03-03 |
4 |
D |
$49.70 |
$26,490 |
D/D |
(533) |
53,304 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP, Finance and Treasurer |
|
2015-06-15 |
4 |
AS |
$66.63 |
$505,055 |
D/D |
(7,580) |
51,958 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
SVP, Finance and Treasurer |
|
2015-06-03 |
4 |
S |
$68.88 |
$1,550,902 |
D/D |
(22,516) |
30,788 |
0 |
- |
|
41 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|